Pamment, Jessica
Regulation of the IRF-1 tumour modifier during the response to genotoxic stress involves an ATM-dependent signalling pathway. [electronic resource]
- Oncogene Nov 2002
- 7776-85 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 0950-9232
Standard No.: 10.1038/sj.onc.1205981 doi
Subjects--Topical Terms: Androstadienes--pharmacology Ataxia Telangiectasia--genetics Ataxia Telangiectasia Mutated Proteins Cell Cycle Proteins Cells, Cultured--metabolism Cyclin-Dependent Kinase Inhibitor p21 Cyclins--physiology Cycloheximide--pharmacology DNA--drug effects DNA Damage DNA-Binding Proteins--biosynthesis Enzyme Inhibitors--pharmacology Etoposide--toxicity Fibroblasts--metabolism Gamma Rays--adverse effects Genes, Reporter Genes, p53 Humans Interferon Regulatory Factor-1 Melanoma--pathology Phosphatidylinositol 3-Kinases--physiology Phosphoinositide-3 Kinase Inhibitors Phosphoproteins--biosynthesis Phosphorylation Poly I-C--pharmacology Protein Processing, Post-Translational Protein Serine-Threonine Kinases--deficiency Protein Synthesis Inhibitors--pharmacology RNA, Messenger--biosynthesis Recombinant Fusion Proteins--biosynthesis Signal Transduction--physiology Transcription, Genetic Tumor Cells, Cultured--metabolism Tumor Suppressor Protein p53--biosynthesis Tumor Suppressor Proteins Wortmannin